• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconEli Lilly

Eli Lilly

Sean McClain wears a lab coat
Startups & Venture
Eli Lilly just placed a $40 million bet on the next injectable boom
By Lily Mae LazarusJuly 1, 2026
Dr. Shiv Rao speaks
Startups & Venture
Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it
By Lily Mae LazarusJune 11, 2026
dave ricks
AI
Tech giants see a cure for cancer in AI. But Eli Lilly’s CEO finds it ‘not particularly good’ at solving biology or chemistry problems
By Jake AngeloMarch 2, 2026
TrumpRx
Commentary
TrumpRx is here and it helps, though a bit less than advertised
By Jeffrey Sonnenfeld, Stephen Henriques, Ferron Chen, Asuka Koda and Vanessa McLennanFebruary 11, 2026
The Siri application icon in October 2025. (Photo: Nikolas Kokovlis/NurPhoto/Getty Images)
Newsletters
Apple will use Google Gemini to power Siri
By Andrew NuscaJanuary 13, 2026
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
Newsletters
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By John KellNovember 19, 2025
Donald Trump
Health
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
By Nick LichtenbergNovember 6, 2025
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
Health
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
By Matty Merritt and Morning BrewOctober 31, 2025
Novo ousts CEO Jorgensen after Lilly competition hits shares
Tech
Novo ousts CEO Jorgensen after Lilly competition hits shares
By Eric Pfanner and BloombergMay 16, 2025
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
Health
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
By Jonel Aleccia and The Associated PressMay 12, 2025
People walking by Viagra Connect ad seen in The Boots Pharmacy window in Dublin during Level 5 Covid-19 lockdown. On Thursday, 28 January, 2021, in Dublin, Ireland.
Politics
Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.
By Ryan HoggApril 30, 2025
Novo Nordisk slides on pressure from Lilly’s pill study
Retail
Novo Nordisk slides on pressure from Lilly’s pill study
By Marthe Fourcade and BloombergApril 22, 2025
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
Retail
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
By Paula Doenecke, Naomi Kresge and BloombergMarch 12, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
Commentary
The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By Wendy BarnesMarch 4, 2025
Eli Lilly's headquarters sits behind a gate with the US flag raised
Finance
Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
By Madison Muller and BloombergFebruary 26, 2025
1
  • 1
  • 2
  • 3
  • 4
  • 5
...7
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.